tiprankstipranks
Bicycle Therapeutics price target lowered to $17 from $28 at B. Riley
PremiumThe FlyBicycle Therapeutics price target lowered to $17 from $28 at B. Riley
1M ago
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
Premium
The Fly
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
1M ago
Cantor Fitzgerald biotech analyst holds an analyst/industry conference call
Premium
The Fly
Cantor Fitzgerald biotech analyst holds an analyst/industry conference call
2M ago
Bicycle Therapeutics: Promising Q3 Results and Business Progress
PremiumCompany AnnouncementsBicycle Therapeutics: Promising Q3 Results and Business Progress
3M ago
Bicycle Therapeutics reports Q3 EPS (74c), consensus (78c)
Premium
The Fly
Bicycle Therapeutics reports Q3 EPS (74c), consensus (78c)
3M ago
BCYC Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
BCYC Earnings this Week: How Will it Perform?
3M ago
Bicycle Therapeutics management to meet with Oppenheimer
PremiumThe FlyBicycle Therapeutics management to meet with Oppenheimer
4M ago
Bicycle says 45% of patients respond to bladder cancer drug, EN reports
Premium
The Fly
Bicycle says 45% of patients respond to bladder cancer drug, EN reports
4M ago
RBC starts Bicycle Therapeutics at Outperform on ‘novel and unique platform’
Premium
The Fly
RBC starts Bicycle Therapeutics at Outperform on ‘novel and unique platform’
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100